Lifestyle changes, like switching up fat sources in your diet or adding more exercise to your weekly routine, may help reduce “bad” LDL cholesterol. If those changes aren’t enough ...

Amgen’s product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha, Kyprolis and Blincyto among others. However, prices of most products are ...

According to the collective judgment of analysts, 'Product Sales- Repatha- Total' should come in at $616.47 million. The estimate indicates a change of +19.2% from the prior-year quarter.

Notable contributors included Repatha (evolocumab) for hypercholesterolemia and hyperlipidemia, Blincyto (blinatumomab) for B-cell acute lymphocytic leukaemia, recently approved in June 2024, and ...

Since Giordano received his results, he’s been taking Repatha, a drug that helps lower cholesterol, and it’s working. “It dropped my cholesterol, my LDL was 140, I think. And it dropped down ...

We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other ...

Other studies are testing more potent agents added to statin therapy. EVOLVE-MI, for instance, is evaluating evolocumab (Repatha; Amgen) given early on top of statin therapy in patients hospitalized ...

On April 10, Dan Ives, Head of Global Tech Research at Wedbush Securities, appeared on an interview at CNBC and expressed that the tech sector could be heading into a period of major volatility.